Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Radcliffe Capital Management, L.P. SABS SAB Biotherapeutics, Inc. 13G/A 0% 2y
LCG Holdings, LLC GFR Greenfire Resources Ltd. 13G/A 3% 2y
Shanghai Wenqian Enterprise Management Center L.P. HSAI Hesai Group 13G 2.71% 2y
PERCEPTIVE ADVISORS LLC SYRE Spyre Therapeutics, Inc. 13G/A 7.2% 2y
T. Rowe Price Investment Management, Inc. ARTNA Artesian Resources Corp 13G 8.2% 2y
RIVERBRIDGE PARTNERS LLC LOPE Grand Canyon Education, Inc. 13G/A 6.15% 2y
Logos Global Management LP ALLK Allakos Inc. 13G/A 3.3% 2y
RA CAPITAL MANAGEMENT, L.P. NKTR Nektar Therapeutics 13G/A 0% 2y
METEORA CAPITAL, LLC QTI Qt Imaging Holdings, Inc. 13G 9.62% 2y
First Trust Capital Management L.P. IRRX Integrated Rail and Resources Acquisition Corp. 13G 5.5% 2y
Intchains ZWM Holding Limited ICG Intchains Group Ltd 13G 13.9% 2y
Brian P. Hannasch NRXS Neuraxis, INC 13G/A 10.3% 2y
NGP XI US Holdings, L.P. CIVI Civitas Resources, Inc. 13G/A 1.75% 2y
IBK Securities Co., Ltd. SMR NUSCALE POWER Corp 13G/A 2.8% 2y
ARMISTICE CAPITAL, LLC SCPH scPharmaceuticals Inc. Common Stock 13G/A 0% 2y
Jacobs Paul Anthony AURX Nuo Therapeutics, Inc. 13G 5.65% 2y
Murray J. Bailey EESH EESTech, Inc. 13G 6.5% 2y
Nantahala Capital Management, LLC NDLS NOODLES & Co 13G 8.3% 2y
Rock Springs Capital Management LP GMDA Gamida Cell Ltd. Ordinary Shares 13G/A 0% 2y
Broad Bay Capital Management, LP EB Eventbrite, Inc. Class A Common Stock 13G/A 4.4% 2y
RTW INVESTMENTS, LP MIST Milestone Pharmaceuticals Inc. 13G/A 9.99% 2y
RTW INVESTMENTS, LP IMCR Immunocore Holdings plc 13G/A 12.3% 2y
Palo Alto Investors LP EHTH eHealth, Inc. 13G/A 9.66% 2y
T. Rowe Price Investment Management, Inc. MGNX Macrogenics Inc 13G 9.1% 2y
Robert E. Beasley BBGI Beasley Broadcast Group Inc 13G/A 5.7% 2y
Dragoneer Investment Group, LLC CARG CarGurus, Inc. 13G/A 1.9% 2y
First Trust Capital Management L.P. MITA Coliseum Acquisition Corp. Class A Ordinary Share 13G 6.4% 2y
PRICE T ROWE ASSOCIATES INC /MD/ ISRG Intuitive Surgical Inc 13G/A 4.8% 2y
CAT ROCK CAPITAL MANAGEMENT LP DCBO Docebo Inc. 13G/A 7.24% 2y
Douglas V. Reynolds FGBI First Guaranty Bancshares, Inc. 13G 5.02% 2y
Global X Management CO LLC DNN Denison Mines Corp. 13G 5.12% 2y
T. Rowe Price Investment Management, Inc. ESI Element Solutions Inc 13G 7.5% 2y
SOROS FUND MANAGEMENT LLC INDI indie Semiconductor, Inc. 13G/A 2.55% 2y
PZENA INVESTMENT MANAGEMENT LLC GIL Gildan Activewear Inc. 13G 5.6% 2y
ArrowMark Colorado Holdings LLC SBH Sally Beauty Holdings, Inc. 13G/A 4.45% 2y
Rock Springs Capital Management LP MREO Mereo BioPharma Group plc 13G/A 5.69% 2y
Cutler Capital Management, LLC SBFG Sb Financial Group, Inc. 13G/A 5.92% 2y
Long Path Partners LP SAMG Silvercrest Asset Management Group Inc. 13G/A 7.8% 2y
ArrowMark Colorado Holdings LLC BYRN Byrna Technologies Inc. 13G/A 9.08% 2y
Lan Huang BYSI BeyondSpring Inc. 13G/A 26.17% 2y
Exor N.V. SBSW Sibanye Stillwater Ltd 13G/A 5.2% 2y
TMD Wealth Management, LLC TNON Tenon Medical, Inc. 13G/A 31.56% 2y
Noah Glass OLO Olo Inc. 13G/A 10.9% 2y
CVI Investments, Inc. ADTX Aditxt, Inc. 13G/A 0.5% 2y
Deep Track Capital, LP INZY Inozyme Pharma, Inc. Common Stock 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. KRTX Karuna Therapeutics, Inc. Common Stock 13G 7.2% 2y
Commodore Capital LP VERA Vera Therapeutics, Inc. 13G/A 12.3% 2y
ArrowMark Colorado Holdings LLC ZD Ziff Davis, Inc. 13G 7.16% 2y
ATLAS Infrastructure Partners (UK) Ltd. POR Portland General Electric Co 13G 5.6% 2y
Atalaya Capital Management LP PEGR Project Energy Reimagined Acquisition Corp. Class A Ordinary Share 13G/A 0% 2y